<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38309955</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1755-3245</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>07</Day></PubDate></JournalIssue><Title>Cardiovascular research</Title><ISOAbbreviation>Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection.</ArticleTitle><Pagination><StartPage>644</StartPage><EndPage>657</EndPage><MedlinePgn>644-657</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cvr/cvae026</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Virus infection triggers inflammation and, may impose nutrient shortage to the heart. Supported by type I interferon (IFN) signalling, cardiomyocytes counteract infection by various effector processes, with the IFN-stimulated gene of 15 kDa (ISG15) system being intensively regulated and protein modification with ISG15 protecting mice Coxsackievirus B3 (CVB3) infection. The underlying molecular aspects how the ISG15 system affects the functional properties of respective protein substrates in the heart are unknown.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Based on the protective properties due to protein ISGylation, we set out a study investigating CVB3-infected mice in depth and found cardiac atrophy with lower cardiac output in ISG15-/- mice. By mass spectrometry, we identified the protein targets of the ISG15 conjugation machinery in heart tissue and explored how ISGylation affects their function. The cardiac ISGylome showed a strong enrichment of ISGylation substrates within glycolytic metabolic processes. Two control enzymes of the glycolytic pathway, hexokinase 2 (HK2) and phosphofructokinase muscle form (PFK1), were identified as bona fide ISGylation targets during infection. In an integrative approach complemented with enzymatic functional testing and structural modelling, we demonstrate that protein ISGylation obstructs the activity of HK2 and PFK1. Seahorse-based investigation of glycolysis in cardiomyocytes revealed that, by conjugating proteins, the ISG15 system prevents the infection-/IFN-induced up-regulation of glycolysis. We complemented our analysis with proteomics-based advanced computational modelling of cardiac energy metabolism. Our calculations revealed an ISG15-dependent preservation of the metabolic capacity in cardiac tissue during CVB3 infection. Functional profiling of mitochondrial respiration in cardiomyocytes and mouse heart tissue by Seahorse technology showed an enhanced oxidative activity in cells with a competent ISG15 system.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study demonstrates that ISG15 controls critical nodes in cardiac metabolism. ISG15 reduces the glucose demand, supports higher ATP production capacity in the heart, despite nutrient shortage in infection, and counteracts cardiac atrophy and dysfunction.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bredow</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biochemistry, Charitéplatz 1, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thery</LastName><ForeName>Fabien</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB-UGent Center for Medical Biotechnology, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirth</LastName><ForeName>Eva Katrin</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Deutsches Zentrum für Herz-Kreislauf-Forschung, partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Endocrinology, Diabetes and Nutrition, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochs</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biochemistry, Charitéplatz 1, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kespohl</LastName><ForeName>Meike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biochemistry, Charitéplatz 1, 10117 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum für Herz-Kreislauf-Forschung, partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinau</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Physics and Biophysics, Group Protein X-ray Crystallography and Signal Transduction, Charitéplatz 1, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelm</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biochemistry, Charitéplatz 1, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gimber</LastName><ForeName>Niclas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Advanced Medical Bioimaging Core Facility, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmoranzer</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Advanced Medical Bioimaging Core Facility, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biochemistry, Charitéplatz 1, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klingel</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Tübingen, Cardiopathology, Institute for Pathology and Neuropathology, Tübingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spranger</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Deutsches Zentrum für Herz-Kreislauf-Forschung, partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Endocrinology, Diabetes and Nutrition, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renko</LastName><ForeName>Kostja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>German Federal Institute for Risk Assessment (BfR), German Centre for the Protection of Laboratory Animals (Bf3R), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ralser</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9535-7413</Identifier><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Core Facility-High-Throughput Mass Spectrometry, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mülleder</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Core Facility-High-Throughput Mass Spectrometry, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heuser</LastName><ForeName>Arnd</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Max-Delbrueck-Center (MDC) for Molecular Medicine, Animal Phenotyping Platform, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knobeloch</LastName><ForeName>Klaus-Peter</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>University of Freiburg, Institute of Neuropathology, Freiburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheerer</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Deutsches Zentrum für Herz-Kreislauf-Forschung, partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Physics and Biophysics, Group Protein X-ray Crystallography and Signal Transduction, Charitéplatz 1, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirwan</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Berlin Institute of Health at Charité Universitätsmedizin, Metabolomics, Charitéplatz 1 Berlin 10117, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brüning</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Berlin Institute of Health at Charité Universitätsmedizin, Metabolomics, Charitéplatz 1 Berlin 10117, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berndt</LastName><ForeName>Nikolaus</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5594-9940</Identifier><AffiliationInfo><Affiliation>German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Department of Molecular Toxicology, Nuthetal, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Herzzentrum der Charité (DHZC), Institute of Computer-assisted Cardiovascular Medicine, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Impens</LastName><ForeName>Francis</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB-UGent Center for Medical Biotechnology, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB Proteomics Core, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beling</LastName><ForeName>Antje</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1826-5248</Identifier><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biochemistry, Charitéplatz 1, 10117 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum für Herz-Kreislauf-Forschung, partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Foundation for Experimental Biomedicine Zurich, Switzerland</Agency><Country /></Grant><Grant><GrantID>39/1216-1</GrantID><Agency>German Research Foundation</Agency><Country /></Grant><Grant><GrantID>SFB958/Z02</GrantID><Agency>International Max Planck Research School for Infectious Diseases and Immunology</Agency><Country /></Grant><Grant><Agency>Advanced Medical Bioimaging Core Facility</Agency><Country /></Grant><Grant><Agency>Charité -Universitätsmedizin</Agency><Country /></Grant><Grant><GrantID>G0F8616N</GrantID><Agency>Research Foundation Flanders</Agency><Country /></Grant><Grant><Agency>Bundesministerium für Bildung und Forschung</Agency><Country /></Grant><Grant><GrantID>031A427A</GrantID><Agency>German Federal Ministry of Education and Research</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Res</MedlineTA><NlmUniqueID>0077427</NlmUniqueID><ISSNLinking>0008-6363</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489550">G1p2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014452">Ubiquitins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="Y">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006019" MajorTopicYN="Y">Glycolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008929" MajorTopicYN="Y">Mitochondria, Heart</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="Y">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014452" MajorTopicYN="Y">Ubiquitins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Glycolysis</Keyword><Keyword MajorTopicYN="N">ISG15</Keyword><Keyword MajorTopicYN="N">ISGylation</Keyword><Keyword MajorTopicYN="N">Metabolism</Keyword><Keyword MajorTopicYN="N">Mitochondrial function</Keyword><Keyword MajorTopicYN="N">Virus infection</Keyword></KeywordList><CoiStatement>Conflict of interest: JK conducts paid consultancy for Centogene GmbH. All other authors declare no conflict of interest. The patent application EP21174633 with the title “Computer assisted method for the evaluation of cardiac metabolism” was filed by Charité – Universitätsmedizin Berlin as the employer of NB and Titus Kuehne, with both holding inventorship for this patent application.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>3</Day><Hour>21</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38309955</ArticleId><ArticleId IdType="pmc">PMC11074791</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvae026</ArticleId><ArticleId IdType="pii">7600410</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet 2012;379:738–747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5814111</ArticleId><ArticleId IdType="pubmed">22185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Althof N, Harkins S, Kemball CC, Flynn CT, Alirezaei M, Whitton JL. In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease. J Virol 2014;88:5087–5099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3993796</ArticleId><ArticleId IdType="pubmed">24574394</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessely R, Klingel K, Knowlton KU, Kandolf R. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling—implications for mortality and early viral replication. Circulation 2001;103:756–761.</Citation><ArticleIdList><ArticleId IdType="pubmed">11156890</ArticleId></ArticleIdList></Reference><Reference><Citation>Koestner W, Spanier J, Klause T, Tegtmeyer PK, Becker J, Herder V, Borst K, Todt D, Lienenklaus S, Gerhauser I, Detje CN, Geffers R, Langereis MA, Vondran FWR, Yuan Q, van Kuppeveld FJM, Ott M, Staeheli P, Steinmann E, Baumgärtner W, Wacker F, Kalinke U. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in coxsackievirus B3-infected mice. PLoS Pathog 2018;14:e1007235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107283</ArticleId><ArticleId IdType="pubmed">30075026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kespohl M, Bredow C, Klingel K, Voss M, Paeschke A, Zickler M, Poller W, Kaya Z, Eckstein J, Fechner H, Spranger J, Fahling M, Wirth EK, Radoshevich L, Thery F, Impens F, Berndt N, Knobeloch KP, Beling A. Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming. Sci Adv 2020;6:eaay1109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7065878</ArticleId><ArticleId IdType="pubmed">32195343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahnefeld A, Klingel K, Schuermann A, Diny NL, Althof N, Lindner A, Bleienheuft P, Savvatis K, Respondek D, Opitz E, Ketscher L, Sauter M, Seifert U, Tschope C, Poller W, Knobeloch KP, Voigt A. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy. Circulation 2014;130:1589–1600.</Citation><ArticleIdList><ArticleId IdType="pubmed">25165091</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S, Dieringer B, Klopfleisch R, Savvatis K, Van Linthout S, Pryshliak M, Tschöpe C, Klingel K, Kurreck J, Beling A, Fechner H. Early treatment of coxsackievirus B3-infected animals with soluble coxsackievirus-adenovirus receptor inhibits development of chronic coxsackievirus B3 cardiomyopathy. Circ Heart Fail 2019;12:e005250.</Citation><ArticleIdList><ArticleId IdType="pubmed">31718319</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol 2018;16:423–439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097117</ArticleId><ArticleId IdType="pubmed">29769653</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzke CC, Althof N, Neumaier HL, Heuser A, Kaya Z, Kespohl M, Klingel K, Beling A. Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection. Basic Res Cardiol 2021;116:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7851025</ArticleId><ArticleId IdType="pubmed">33523326</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S, Kespohl M, Kelm N, Kaya Z, Heuser A, Klingel K, Beling A. Exploration of analgesia with tramadol in the coxsackievirus B3 myocarditis mouse model. Viruses 2021;13:1222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310306</ArticleId><ArticleId IdType="pubmed">34202636</ArticleId></ArticleIdList></Reference><Reference><Citation>Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res 2013;113:709–724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896379</ArticleId><ArticleId IdType="pubmed">23989714</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg J, Tymoczko JL, Stryer L. Biochemistry. Basingstoke: W.H. Freeman; 2012.</Citation></Reference><Reference><Citation>Burke JD, Platanias LC, Fish EN. Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3. J Virol 2014;88:3485–3495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957914</ArticleId><ArticleId IdType="pubmed">24403577</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Sanin DE, Everts B, Chen Q, Qiu J, Buck MD, Patterson A, Smith AM, Chang CH, Liu Z, Artyomov MN, Pearce EL, Cella M, Pearce EJ. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity 2016;44:1325–1336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5695232</ArticleId><ArticleId IdType="pubmed">27332732</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldanta S, Fernandez-Escobar M, Acin-Perez R, Albert M, Camafeita E, Jorge I, Vazquez J, Enriquez JA, Guerra S. ISG15 governs mitochondrial function in macrophages following vaccinia virus infection. PLoS Pathog 2017;13:e1006651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5659798</ArticleId><ArticleId IdType="pubmed">29077752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketscher L, Hannss R, Morales DJ, Basters A, Guerra S, Goldmann T, Hausmann A, Prinz M, Naumann R, Pekosz A, Utermohlen O, Lenschow DJ, Knobeloch KP. Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. Proc Natl Acad Sci U S A 2015;112:1577–1582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4321242</ArticleId><ArticleId IdType="pubmed">25605921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 2006;26:472–479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1346917</ArticleId><ArticleId IdType="pubmed">16382139</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 2005;25:6338–6345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1190360</ArticleId><ArticleId IdType="pubmed">16024773</ArticleId></ArticleIdList></Reference><Reference><Citation>Opitz E, Koch A, Klingel K, Schmidt F, Prokop S, Rahnefeld A, Sauter M, Heppner FL, Volker U, Kandolf R, Kuckelkorn U, Stangl K, Kruger E, Kloetzel PM, Voigt A. Impairment of immunoproteasome function by beta5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathog 2011;7:e1002233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3164653</ArticleId><ArticleId IdType="pubmed">21909276</ArticleId></ArticleIdList></Reference><Reference><Citation>He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95:2509–2514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19394</ArticleId><ArticleId IdType="pubmed">9482916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Thery F, Wu NC, Luhmann EK, Dussurget O, Foecke M, Bredow C, Jimenez-Fernandez D, Leandro K, Beling A, Knobeloch KP, Impens F, Cossart P, Radoshevich L. The in vivo ISGylome links ISG15 to metabolic pathways and autophagy upon Listeria monocytogenes infection. Nat Commun 2019;10:5383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6879477</ArticleId><ArticleId IdType="pubmed">31772204</ArticleId></ArticleIdList></Reference><Reference><Citation>Berndt N, Eckstein J, Wallach I, Nordmeyer S, Kelm M, Kirchner M, Goubergrits L, Schafstedde M, Hennemuth A, Kraus M, Grune T, Mertins P, Kuehne T, Holzhütter HG. CARDIOKIN1: computational assessment of myocardial metabolic capability in healthy controls and patients with valve diseases. Circulation 2021;144:1926–1939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8663543</ArticleId><ArticleId IdType="pubmed">34762513</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, Inuganti A, Griss J, Mayer G, Eisenacher M, Perez E, Uszkoreit J, Pfeuffer J, Sachsenberg T, Yilmaz S, Tiwary S, Cox J, Audain E, Walzer M, Jarnuczak AF, Ternent T, Brazma A, Vizcaino JA. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 2019;47:D442–D450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323896</ArticleId><ArticleId IdType="pubmed">30395289</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakopoulos NV, Arutyunova E, Lai C, Lenschow DJ, Haas AL, Virgin HW. ISG15 arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J Virol 2009;83:1602–1610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2643764</ArticleId><ArticleId IdType="pubmed">19073728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 2005;102:10200–10205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1177427</ArticleId><ArticleId IdType="pubmed">16009940</ArticleId></ArticleIdList></Reference><Reference><Citation>Radoshevich L, Impens F, Ribet D, Quereda JJ, Nam Tham T, Nahori MA, Bierne H, Dussurget O, Pizarro-Cerda J, Knobeloch KP, Cossart P. ISG15 counteracts Listeria monocytogenes infection. Elife 2015;4:e06848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4530601</ArticleId><ArticleId IdType="pubmed">26259872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S, Kumari M, Xiao H, Jacobs C, Kochumon S, Jedrychowski M, Chouchani E, Ahmad R, Rosen ED. IRF3 reduces adipose thermogenesis via ISG15-mediated reprogramming of glycolysis. J Clin Invest 2021;131:e144888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011904</ArticleId><ArticleId IdType="pubmed">33571167</ArticleId></ArticleIdList></Reference><Reference><Citation>Durfee LA, Lyon N, Seo K, Huibregtse JM. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 2010;38:722–732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887317</ArticleId><ArticleId IdType="pubmed">20542004</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H, Zeng J, Xie R, Schulz MJ, Tedesco R, Qu J, Erhard KF, Mack JF, Raha K, Rendina AR, Szewczuk LM, Kratz PM, Jurewicz AJ, Cecconie T, Martens S, McDevitt PJ, Martin JD, Chen SB, Jiang Y, Nickels L, Schwartz BJ, Smallwood A, Zhao B, Campobasso N, Qian Y, Briand J, Rominger CM, Oleykowski C, Hardwicke MA, Luengo JI. Discovery of a novel 2,6-disubstituted glucosamine series of potent and selective hexokinase 2 inhibitors. ACS Med Chem Lett 2016;7:217–222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4789681</ArticleId><ArticleId IdType="pubmed">26985301</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasimhan J, Wang M, Fu Z, Klein JM, Haas AL, Kim JJ. Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J Biol Chem 2005;280:27356–27365.</Citation><ArticleIdList><ArticleId IdType="pubmed">15917233</ArticleId></ArticleIdList></Reference><Reference><Citation>Daczkowski CM, Goodwin OY, Dzimianski JV, Farhat JJ, Pegan SD. Structurally guided removal of DeISGylase biochemical activity from papain-like protease originating from Middle East respiratory syndrome coronavirus. J Virol 2017;91:e01067-17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5686735</ArticleId><ArticleId IdType="pubmed">28931677</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T, Wang C, Wu M, Zhang X, Zang J. Structural insights into the regulation of staphylococcus aureus phosphofructokinase by tetramer-dimer conversion. Biochemistry 2018;57:4252–4262.</Citation><ArticleIdList><ArticleId IdType="pubmed">29940104</ArticleId></ArticleIdList></Reference><Reference><Citation>Mookerjee SA, Brand MD. Measurement and analysis of extracellular acid production to determine glycolytic rate. J Vis Exp 2015:e53464. doi:10.3791/53464</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/53464</ArticleId><ArticleId IdType="pmc">PMC4692795</ArticleId><ArticleId IdType="pubmed">26709455</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun SH, Chen Q, Gu HJ, Yang G, Wang YX, Huang XY, Liu SS, Zhang NN, Li XF, Xiong R, Guo Y, Deng YQ, Huang WJ, Liu Q, Liu QM, Shen YL, Zhou Y, Yang X, Zhao TY, Fan CF, Zhou YS, Qin CF, Wang YC. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe 2020;28:124–133.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250783</ArticleId><ArticleId IdType="pubmed">32485164</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HW. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and sindbis viruses. Proc Natl Acad Sci U S A 2007;104:1371–1376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1783119</ArticleId><ArticleId IdType="pubmed">17227866</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med 2016;213:15–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4710204</ArticleId><ArticleId IdType="pubmed">26694970</ArticleId></ArticleIdList></Reference><Reference><Citation>Eagle H, Habel K. The nutritional requirements for the propagation of poliomyelitis virus by the HeLa cell. J Exp Med 1956;104:271–287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2136654</ArticleId><ArticleId IdType="pubmed">13345971</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcalá S, Sancho P, Martinelli P, Navarro D, Pedrero C, Martín-Hijano L, Valle S, Earl J, Rodríguez-Serrano M, Ruiz-Cañas L, Rojas K, Carrato A, García-Bermejo L, Fernández-Moreno M, Hermann PC, Sainz B Jr. ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity. Nat Commun 2020;11:2682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260233</ArticleId><ArticleId IdType="pubmed">32472071</ArticleId></ArticleIdList></Reference><Reference><Citation>Murashige D, Jang C, Neinast M, Edwards JJ, Cowan A, Hyman MC, Rabinowitz JD, Frankel DS, Arany Z. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science 2020;370:364–368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7871704</ArticleId><ArticleId IdType="pubmed">33060364</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, Zhu LH, Wang C. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 2010;30:2424–2436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2863703</ArticleId><ArticleId IdType="pubmed">20308324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>